Cynosure Group LLC Invests $328,000 in The Procter & Gamble Company (NYSE:PG)

Cynosure Group LLC purchased a new position in The Procter & Gamble Company (NYSE:PGFree Report) during the 3rd quarter, HoldingsChannel.com reports. The fund purchased 1,896 shares of the company’s stock, valued at approximately $328,000.

Other institutional investors have also added to or reduced their stakes in the company. Boston Partners increased its position in Procter & Gamble by 2.8% during the 1st quarter. Boston Partners now owns 33,483 shares of the company’s stock valued at $5,433,000 after buying an additional 902 shares in the last quarter. Westwood Holdings Group Inc. boosted its stake in Procter & Gamble by 6.6% in the 1st quarter. Westwood Holdings Group Inc. now owns 7,158 shares of the company’s stock worth $1,161,000 after purchasing an additional 446 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in Procter & Gamble by 48.2% during the 1st quarter. EverSource Wealth Advisors LLC now owns 10,700 shares of the company’s stock valued at $1,746,000 after purchasing an additional 3,482 shares in the last quarter. ShankerValleau Wealth Advisors Inc. raised its holdings in Procter & Gamble by 7.1% in the second quarter. ShankerValleau Wealth Advisors Inc. now owns 1,466 shares of the company’s stock worth $242,000 after buying an additional 97 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Procter & Gamble by 67.2% in the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after buying an additional 10,777 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Up 0.0 %

PG stock opened at $179.37 on Friday. The business’s 50-day moving average price is $170.48 and its 200-day moving average price is $169.07. The stock has a market cap of $422.42 billion, a P/E ratio of 30.93, a PEG ratio of 3.86 and a beta of 0.42. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a twelve month low of $142.50 and a twelve month high of $180.43.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company’s revenue for the quarter was down .6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.83 earnings per share. On average, equities research analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $1.0065 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.24%. Procter & Gamble’s payout ratio is presently 69.31%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on PG. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Morgan Stanley upped their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective on the stock in a research report on Thursday, August 29th. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Finally, Piper Sandler initiated coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target on the stock. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $180.45.

Get Our Latest Stock Report on PG

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the completion of the sale, the insider now directly owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This trade represents a 52.47 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Susan Street Whaley sold 634 shares of the business’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares in the company, valued at $3,319,882.65. This trade represents a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 35,233 shares of company stock valued at $6,024,234 over the last ninety days. 0.18% of the stock is currently owned by company insiders.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.